Randomized Comparison of Ceftriaxone versus Cefriaxone plus Amikacin for the Empirical Treatment of Infections in Patients with Altered Host Defense: Microbiological and Clinical Evaluation-Reference-Cited by-同舟云学术

Randomized Comparison of Ceftriaxone versus Cefriaxone plus Amikacin for the Empirical Treatment of Infections in Patients with Altered Host Defense: Microbiological and Clinical Evaluation

Published:1992 Issue:6 Volume:38 Page:420-427
ISSN:0009-3157
Container-title:Chemotherapy
language:en
Short-container-title:Chemotherapy

Author:

D’;Antonio D.,Fioritoni G.,Iacone A.,Dell’;Isola M.,Natale D.,D’;Arcangelo L.,Betti S.,Spadano A.,Recchia A.,Mastrangelo C.,Di Gianfilippo R.,Piergallini A.,Accorsi P.,Quaglietta A.,Torlontano G.

Publisher

S. Karger AG

Subject

Infectious Diseases,Pharmacology (medical),Drug Discovery,Pharmacology,Oncology,General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis;Cochrane Database of Systematic Reviews;2014-01-07

2. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia;Cochrane Database of Systematic Reviews;2013-06-29

3. Clinical implications of β-lactam–aminoglycoside synergism: systematic review of randomised trials;International Journal of Antimicrobial Agents;2011-06

4. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study;Critical Care Medicine;2010-08

5. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis;Cochrane Database of Systematic Reviews;2006-01-25